150 related articles for article (PubMed ID: 11320855)
1. [The return of thalidomide].
Rossi G
Recenti Prog Med; 2001 Mar; 92(3):213-6. PubMed ID: 11320855
[TBL] [Abstract][Full Text] [Related]
2. Dermatologic therapeutics: thalidomide. A practical guide.
Rosenbach M; Werth VP
Dermatol Ther; 2007; 20(4):175-86. PubMed ID: 17970884
[TBL] [Abstract][Full Text] [Related]
3. [The revival of thalidomide: an old drug with new indications].
Laffitte E
Rev Prat; 2006 Nov; 56(18):1977-83. PubMed ID: 17274497
[TBL] [Abstract][Full Text] [Related]
4. [Thalidomide: new uses for an old drug].
Wu KL; Sonneveld P
Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008
[TBL] [Abstract][Full Text] [Related]
5. [Thalidomide: new indications for an old drug].
Laffitte E
Rev Med Suisse; 2005 Apr; 1(16):1074, 1077-80. PubMed ID: 15934472
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide: current and potential clinical applications.
Calabrese L; Fleischer AB
Am J Med; 2000 Apr; 108(6):487-95. PubMed ID: 10781782
[TBL] [Abstract][Full Text] [Related]
7. Dermatologic and nondermatologic uses of thalidomide.
Nasca MR; Micali G; Cheigh NH; West LE; West DP
Ann Pharmacother; 2003 Sep; 37(9):1307-20. PubMed ID: 12921515
[TBL] [Abstract][Full Text] [Related]
8. Thalidomid: current role in the treatment of non-plasma cell malignancies.
Kumar S; Witzig TE; Rajkumar SV
J Clin Oncol; 2004 Jun; 22(12):2477-88. PubMed ID: 15197211
[TBL] [Abstract][Full Text] [Related]
9. A review of thalidomide's history and current dermatological applications.
Perri AJ; Hsu S
Dermatol Online J; 2003 Aug; 9(3):5. PubMed ID: 12952752
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide and its dermatologic uses.
Paghdal KV; Schwartz R
Acta Dermatovenerol Croat; 2007; 15(1):39-44. PubMed ID: 17433179
[TBL] [Abstract][Full Text] [Related]
11. Innovative uses of thalidomide.
Chen M; Doherty SD; Hsu S
Dermatol Clin; 2010 Jul; 28(3):577-86. PubMed ID: 20510766
[TBL] [Abstract][Full Text] [Related]
12. Thalidomide: an antineoplastic agent.
Amato RJ
Curr Oncol Rep; 2002 Jan; 4(1):56-62. PubMed ID: 11734114
[TBL] [Abstract][Full Text] [Related]
13. Thalidomide: mechanisms of action.
Paravar T; Lee DJ
Int Rev Immunol; 2008; 27(3):111-35. PubMed ID: 18437602
[TBL] [Abstract][Full Text] [Related]
14. [Should thalidomide be rehabilitated?].
Belaube P; Garcin G; Marchand JP; Privat Y
Sem Hop; 1983 Dec; 59(45):3101-4. PubMed ID: 6320398
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide: a re-look.
Grover JK; Vats V; Gopalakrishna R; Ramam M
Natl Med J India; 2000; 13(3):132-41. PubMed ID: 11558112
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide: 40 years on.
Diggle GE
Int J Clin Pract; 2001 Nov; 55(9):627-31. PubMed ID: 11770361
[TBL] [Abstract][Full Text] [Related]
17. Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses.
Tseng S; Pak G; Washenik K; Pomeranz MK; Shupack JL
J Am Acad Dermatol; 1996 Dec; 35(6):969-79. PubMed ID: 8959957
[TBL] [Abstract][Full Text] [Related]
18. [Role of thalidomide in the treatment of multiple myeloma].
Mikala G; Jákó J; Vályi-Nagy I
Orv Hetil; 2001 Aug; 142(33):1789-98. PubMed ID: 11573449
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide and analogues: potential for immunomodulation of inflammatory and neoplastic dermatologic disorders.
Ladizinski B; Shannon EJ; Sanchez MR; Levis WR
J Drugs Dermatol; 2010 Jul; 9(7):814-26. PubMed ID: 20677538
[TBL] [Abstract][Full Text] [Related]
20. The promise of thalidomide: evolving indications.
Joglekar S; Levin M
Drugs Today (Barc); 2004 Mar; 40(3):197-204. PubMed ID: 15148528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]